Properties (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Disease
|
| gptkbp:associatedWith |
autoimmune diseases
smoking certain medications exposure to pollutants |
| gptkbp:causedBy |
environmental factors
genetic factors idiopathic_factors |
| gptkbp:clinicalTrials |
NICE guidelines
EULAR recommendations ATS/ERS guidelines FDA_recommendations |
| gptkbp:diseaseResistance |
variable
high-resolution CT scan lung_biopsy |
| gptkbp:educational_programs |
gptkb:Mayo_Clinic
gptkb:National_Institutes_of_Health gptkb:Cleveland_Clinic gptkb:American_Thoracic_Society |
| gptkbp:events |
Pulmonary Fibrosis Awareness Month
|
| gptkbp:globalPresence |
estimated 3-20 cases per 100,000 people
|
| gptkbp:growthRate |
varies by region
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pulmonary Fibrosis
|
| gptkbp:impact |
gptkb:lung_transplant
lungs pulmonary rehabilitation oxygen therapy antifibrotic medications |
| gptkbp:relatedPatent |
gptkb:pulmonary_hypertension
lung cancer respiratory failure heart problems |
| gptkbp:research |
pharmaceutical companies
private donations foundations NIH_funding |
| gptkbp:researchFocus |
biomarkers
clinical trials treatment options pathogenesis |
| gptkbp:riskManagement |
age
family history gender certain occupations |
| gptkbp:supports |
gptkb:American_Lung_Association
gptkb:Pulmonary_Fibrosis_Foundation PF Warriors Pulmonary_Fibrosis_Support_Group |
| gptkbp:symptoms |
fatigue
shortness of breath chronic cough |